Optimization of a High-Throughput Assay for Calcium Channel Modulators on IonWorks Barracuda

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Assay and drug development technologies

• Publication date

  2016-03-01

• Fields of study

  Medicine, Chemistry, Engineering

• Identifiers
  DOI 10.1089/adt.2015.678PMID 26716356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BENZENESULFONAMIDE COMPOUNDS AND THE USE THEREOF BACKGROUND OF THE INVENTION

  2017cited by this paper
• Chelation in metal intoxication--Principles and paradigms.

  2015cited by this paper
• Predicting changes in cardiac myocyte contractility during early drug discovery with in vitro assays.

  2014cited by this paper
• Evaluating State Dependence and Subtype Selectivity of Calcium Channel Modulators in Automated Electrophysiology Assays

  2014cited by this paper
• Ziconotide: a clinical update and pharmacologic review

  2013cited by this paper
• Development of a high-throughput electrophysiological assay for the human ether-à-go-go related potassium channel hERG.

  2013cited by this paper
• Use of Escin as a Perforating Agent on the IonWorks Quattro Automated Electrophysiology Platform

  2013cited by this paper
• Establishment of a secondary screening assay for P/Q-type calcium channel blockers.

  2013cited by this paper
• Validation of a High-Throughput, Automated Electrophysiology Platform for the Screening of Nicotinic Agonists and Antagonists

  2013cited by this paper
• Ion channels as therapeutic targets: a drug discovery perspective.

  2013cited by this paper
• Characterization of the Substituted N-Triazole Oxindole TROX-1, a Small-Molecule, State-Dependent Inhibitor of Cav2 Calcium Channels

  2012cited by this paper
• A novel series of pyrazolylpiperidine N-type calcium channel blockers.

  2012cited by this paper
• Automated Electrophysiology Makes the Pace for Cardiac Ion Channel Safety Screening

  2011cited by this paper
• High-throughput electrophysiology: an emerging paradigm for ion-channel screening and physiology

  2008cited by this paper
• A High-Throughput Assay for Evaluating State Dependence and Subtype Selectivity of Cav2 Calcium Channel Inhibitors

  2008cited by this paper
• Functional biology of the α 2 δ subunits of voltage-gated calcium channels

  2007cited by this paper
• Population patch clamp electrophysiology: a breakthrough technology for ion channel screening.

  2007cited by this paper
• Automated electrophysiology in drug discovery.

  2007cited by this paper
• Functional biology of the alpha(2)delta subunits of voltage-gated calcium channels.

  2007cited by this paper
• Pharmacological characterization of recombinant N-type calcium channel (Cav2.2) mediated calcium mobilization using FLIPR.

  2006cited by this paper
• Targeting chronic and neuropathic pain: The N-type calcium channel comes of age

  2005cited by this paper
• Calcium channel blockers: an update.

  2004cited by this paper
• State-dependent inhibition of L-type calcium channels: cell-based assay in high-throughput format.

  2004cited by this paper
• Inhibition of Cav3.1 channel by silver ions.

  2003cited by this paper
• Barium block of Kir2 and human cardiac inward rectifier currents: evidence for subunit-heteromeric contribution to native currents.

  2003cited by this paper
• Identification and Characterization of Novel Human Cav2.2 (α1B) Calcium Channel Variants Lacking the Synaptic Protein Interaction Site

  2002cited by this paper
• Calcium-dependent inactivation of neuronal calcium channels

  2002cited by this paper
• Kinetics and state-dependent effects of verapamil on cardiac L-type calcium channels

  1996cited by this paper
• Dihydropyridines, phenylalkylamines and benzothiazepines block N-, P/Q- and R-type calcium currents

  1995cited by this paper
• Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).

  1995cited by this paper
• Potent and reversible interaction of silver with pure Na,K-ATPase and Na,K-ATPase-liposomes.

  1994influential reference
• Variable, voltage‐dependent, blocking effects of nitrendipine, verapamil, diltiazem, cinnarizine and cadmium on adrenomedullary secretion

  1989cited by this paper
• DMSA and DMPS--water soluble antidotes for heavy metal poisoning.

  1983influential reference
• Lidocaine block of cardiac sodium channels

  1983cited by this paper

• Therapeutic Antibodies Targeting Potassium Ion Channels.

  2021cites this paper
• The α2,3-selective potentiator of GABAA receptors, KRM-II-81, reduces nociceptive-associated behaviors induced by formalin and spinal nerve ligation in rats.

  2019cites this paper
• Voltage-Gated Sodium Channel Drug Discovery Technologies and Challenges

  2018cites this paper
• High-throughput electrophysiological assays for voltage gated ion channels using SyncroPatch 768PE

  2017cites this paper